- Home
- ONDS vs CRBU Comparison
ONDS vs CRBU Comparison
Compare ONDS & CRBU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- CRBU
- Stock Information
- Founded
- ONDS 2014
- CRBU 2011
- Country
- ONDS United States
- CRBU United States
- Employees
- ONDS N/A
- CRBU N/A
- Industry
- ONDS Telecommunications Equipment
- CRBU Medicinal Chemicals and Botanical Products
- Sector
- ONDS Telecommunications
- CRBU Health Care
- Exchange
- ONDS Nasdaq
- CRBU Nasdaq
- Market Cap
- ONDS 108.4M
- CRBU 93.0M
- IPO Year
- ONDS N/A
- CRBU 2021
- Fundamental
- Price
- ONDS $1.10
- CRBU $0.84
- Analyst Decision
- ONDS Buy
- CRBU Strong Buy
- Analyst Count
- ONDS 1
- CRBU 5
- Target Price
- ONDS $4.00
- CRBU $11.80
- AVG Volume (30 Days)
- ONDS 12.3M
- CRBU 971.0K
- Earning Date
- ONDS 03-12-2025
- CRBU 03-10-2025
- Dividend Yield
- ONDS N/A
- CRBU N/A
- EPS Growth
- ONDS N/A
- CRBU N/A
- EPS
- ONDS N/A
- CRBU N/A
- Revenue
- ONDS $7,192,694.00
- CRBU $9,994,000.00
- Revenue This Year
- ONDS $374.26
- CRBU $3.50
- Revenue Next Year
- ONDS $94.33
- CRBU $177.84
- P/E Ratio
- ONDS N/A
- CRBU N/A
- Revenue Growth
- ONDS N/A
- CRBU N/A
- 52 Week Low
- ONDS $0.54
- CRBU $0.84
- 52 Week High
- ONDS $3.40
- CRBU $4.97
- Technical
- Relative Strength Index (RSI)
- ONDS 55.41
- CRBU 32.10
- Support Level
- ONDS $0.72
- CRBU $0.88
- Resistance Level
- ONDS $1.25
- CRBU $1.01
- Average True Range (ATR)
- ONDS 0.13
- CRBU 0.08
- MACD
- ONDS 0.08
- CRBU 0.00
- Stochastic Oscillator
- ONDS 75.00
- CRBU 2.01
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About CRBU Caribou Biosciences Inc.
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.